Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Revenue | $26.2M | $18.8M | $24.1M | $28.7M | $34.1M |
| Cost of revenue | $12.4M | $9.1M | $12.7M | $15.2M | $17.4M |
| Gross profit | $13.8M | $9.8M | $11.4M | $13.5M | $16.6M |
| Gross margin | 52.6% | 51.9% | 47.1% | 47.0% | 48.8% |
| R&D | $0 | $0 | $0 | $0 | $77.0K |
| Operating income | −$14.9M | −$8.3M | −$25.9M | −$22.4M | −$22.7M |
| EBITDA | −$8.1M | −$7.5M | −$36.8M | $934.0K | −$18.5M |
| Net income | −$11.0M | −$11.0M | −$37.7M | −$640.0K | −$20.1M |
| Net margin | -41.9% | -58.3% | -156.5% | -2.2% | -59.1% |
| EPS (diluted) | -18.09 | -18.94 | -44.10 | -0.61 | -13.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $77M | $2.36 | $2.36–$2.36 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds BFFTF.
No tracked institution reports a position in BFFTF as of their last filing.
No one on the platform has traded BFFTF yet.
| $16M |
| — |
| PCHMPharmChem, Inc. | $3.75 | +0.27% | $22M | — |
| RAMMFRAMM Pharma Corp. | $0.06 | +0.00% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.